SGO 2022 Conference Coverage on VuMedi
Video Player is loading.
10 seconds
Playback speed
SGO 2022 Phase II Trial of Maintenance Niraparib in Stage III/IV or Platinum-Sensitive Recurrent Uterine Serous Carcinoma
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Marina Frimer
By
SGO 2022 Conference Coverage on VuMedi
FEATURING
Marina Frimer
Comments 0
Login to view comments.
Click here to Login
